CCI nod for Wipro GE and GE India technology deal

The regulatory body has approved Wipro GE’s proposed deal to buy GE groups’ biological assets


GE India Technology Centre renders 100 percent of its services to the affiliates of GE group across the world

Wipro GE Healthcare's plan to acquire GE group's assets related to biotechnology and lifesciences have received a green signal from the Competition Commission of India (CCI).

Wipro GE is engaged in manufacturing and distributing various medical equipment and devices while GE India Technology is into multi-disciplinary research and development in varied fields such as biotechnology.

As per the deal, Wipro GE will acquire assets of the GE India Technology Center used for research in areas of biotechnology and lifesciences.

"The proposed combination would facilitate vertical integration of the businesses of Wipro GE. It would enable it to sell equipment as well as provide related research and other support services in biotech and lifescience areas.  Accordingly, it is observed that there is no horizontal overlap between the businesses of Wipro GE and GE India Technology Center" CCI said in an order.

"It is also observed that GE India Technology Center renders 100 percent of its services to the affiliates of GE group across the world, including India," it further said.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email